RxDoctor Payments Data

Gregory Oliver

Family Medicine · Indianapolis, INNPI 1285638254

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 26.7% of the total. Reporting peaked in 2019 at $572 and has fallen 89.9% since, to $58 in 2024.

$1,180in general payments, 2019–2025

Across 79 payments — averaging $14.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$315
  • AbbVie$217
  • Novo Nordisk$188
  • Pfizer$53
  • GSK$49
  • Boehringer Ingelheim$45
  • plus $313 from 13 others

What the payments were for

  • Food & beverage$1,17499%
  • Education$61%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,180 in reported general payments places this provider in the 60th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana →

Other family medicine in Indianapolis

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →